Showing 1 to 10 of 102 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
MA.39 NCT03488693  Recruiting
|
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Breast |
Dr. Thierry Muanza Arielle Langburt 514-340-8222 poste 26801 |
|
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
MA.39 NCT03488693 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Breast |
Dr. Pierre Rousseau Diane Trudel 514-890-8000 poste 11181 |
|
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
MA.39 NCT03488693 Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Breast |
Dr. Sawyna Provencher Sophie Couture 819-346-1110 poste 14311 |
|
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
MAC.19 NCT01901094 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DU SAINT-SACREMENT
|
Breast |
Dr. Christine Desbiens Nathalie Carmichael 418-682-7511 poste 4551 |
|
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
MA.39 NCT03488693 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Breast |
Dr. Valérie Théberge Josée Allard 418-525-4444 poste 16730 |
|
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
MAC.19 NCT01901094 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Breast |
Dr. Mark Basik Gabi Alexandru-Rolea 514-340-8222 poste 25526 |
|
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
NRG-BR003 NCT02488967 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Breast |
Dr. Michael Thirlwell Stelliana Moreno 514-934-1934 poste 43131 |
|
A randomized trial of regional radiotherapy in biomarker low risk node positive breast cancer
MA.39 NCT03488693 Recruiting
|
CISSS DE LAVAL
HOPITAL DE LA CITE-DE-LA-SANTE
|
Breast |
Dr. Isabelle Roy Solange Tremblay 450-668-1010 poste 23603 |
|
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Intensive Loperamide Prophylaxis
PUMA-NER-6201 NCT02400476 Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Breast |
Dr. Michael Thirlwell Stelliana Moreno 514-934-1934 poste 43131 |
|
Étude Pilote de Phase II Sur l'Effet du méthylphénidate Sur la Fonction Cognitive Des Patientes en rémission d'un Cancer du Sein
CogMet NCT02970500 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
|
Breast |
Dr. Bruno Gagnon Mauranne Labonté 418-525-4444 poste 52715 |
Groupe d'étude en oncologie du Québec